CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 186,395 shares at an average $10.36 ($1,931,337)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 21,900 shares at $10.53 ($230,607)
- 4 Open-market sale SVP, CFO, Sec & Treasurer sold 12,450 shares at $10.53 ($131,099)
- 4 Open-market sale SVP & Chief Medical Officer sold 8,940 shares at $10.54 ($94,228)
- 4 Open-market sale Director sold 4,804 shares at $10.69 ($51,335)
- 4 Shares withheld for taxes President and CEO gave up 24,947 shares (to pay taxes)
- 4 Open-market buy 10% owner bought 162,014 shares at an average $14.40 ($2,332,713)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 14 of 29 · 579 filings